Skip to main content

Thrombotic / Thromboembolic Disorder News

Related terms: Budd-Chiari syndrome, Hepatic vein obstruction, Budd-Chiari, Factor V Leiden, Prothrombin G20210A Mutation

Blood Clot Risk From Contraceptive Pills Ends Soon After Women Stop Taking Them

FRIDAY, Nov. 10, 2023 – Women and their doctors have long known that taking birth control pills can elevate the risk for a blood clot. Now, some good news: That added risk will disappear within a...

Socioeconomic Disparities ID'd in Thrombolysis, Thrombectomy Use

THURSDAY, Nov. 2, 2023 – There are socioeconomic disparities in use of thrombolysis or thrombectomy for acute ischemic stroke in Canada, according to a study published online Nov. 1 in Neurology....

FDA Approves Defitelio (defibrotide sodium) for Hepatic Veno-Occlusive Disease Following Hematopoietic Stem-Cell Transplantation

March 30, 2016 – The U.S. Food and Drug Administration today approved Defitelio (defibrotide sodium) to treat adults and children who develop hepatic veno-occlusive disease (VOD) with additional...

FDA Medwatch Alert: Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), In 0.9 percent Sodium Chloride Injection, 500 mL by Hospira: Recall - Particulate Matter

ISSUE: Hospira, Inc. announced a voluntary nationwide user-level recall of one lot of Heparin Sodium, 1,000 USP Heparin Units/500 mL (2 USP Heparin Units/mL), in 0.9% Sodium Chloride Injection, 500...

Ask a question

To post your own question to this support group, sign in or create an account.

Further information

Related drug support groups

warfarin, Coumadin